California City, California, United StatesFounded 20235+ employeesPrivate
$8.7M raisedSeed· last: seed (Mar 2025)· 2 rounds
Backed by(8 investors)
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
